We recently compiled a list of the 12 Healthcare Stocks with Insider Buying in 2025. Caris Life Sciences, Inc. is one of them. Caris Life Sciences, Inc. (NASDAQ:CAI) is advancing its position as a leader in precision medicine by combining whole exome and transcriptome sequencing with AI-driven insights to support cancer detection, monitoring, and therapy selection. The company delivered strong second-quarter results for 2025, reporting $181.4 million in revenue, up 81% year-over-year, with molecular prof ...